Diagnos Laboratorium Utama PT Tbk Cash Flow-to-Debt Ratio
Diagnos Laboratorium Utama PT Tbk cash flow-to-debt ratio. Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of Rp1.52 Billion could theoretically repay 0% of its total liabilities (Rp110.07 Billion) in one year. Check DGNS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Diagnos Laboratorium Utama PT Tbk (2017–2024)
Cash flow-to-debt ratio of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. Historical debt coverage capacity for Diagnos Laboratorium Utama PT Tbk across 8 annual periods. Check how high is Diagnos Laboratorium Utama PT Tbk's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Diagnos Laboratorium Utama PT Tbk Cash Flow-to-Debt Ratio by Year (2017–2024)
Diagnos Laboratorium Utama PT Tbk cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Diagnos Laboratorium Utama PT Tbk. For the full cash flow conversion analysis, see Diagnos Laboratorium Utama PT Tbk (DGNS) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (IDR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | Rp27.30 Billion | Rp103.89 Billion | ▲ +51.2% |
| 2023 | 0.17x | Rp13.18 Billion | Rp75.88 Billion | ▲ +185.2% |
| 2022 | -0.20x | Rp-6.02 Billion | Rp29.51 Billion | ▼ -113.9% |
| 2021 | 1.47x | Rp58.87 Billion | Rp40.18 Billion | ▲ +87.2% |
| 2020 | 0.78x | Rp26.23 Billion | Rp33.51 Billion | ▼ -10.8% |
| 2019 | 0.88x | Rp11.20 Billion | Rp12.76 Billion | ▲ +15.7% |
| 2018 | 0.76x | Rp8.47 Billion | Rp11.17 Billion | ▲ +661.0% |
| 2017 | -0.14x | Rp-712.00 Million | Rp5.27 Billion | — |